Yan Sun
Impact in
- Acoustics and Ultrasonics top 5%
- Oncology top 2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Treatments and Mutations 6
- Renal cell carcinoma treatment 4
- Co-authors
- Xiangchun Li (2 shared papers)Meng Yang (1 shared paper)Shuhao Wang (1 shared paper)Yahui Jiang (1 shared paper)James Chih‐Hsin Yang (2 shared papers)Keunchil Park (2 shared papers)Mengzhao Wang (2 shared papers)Lucio Crinò (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (4 papers)Modern Pathology (3 papers)Frontiers in Pediatrics (3 papers)Frontiers in Cardiovascular Medicine (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yan Sun
123 papers receiving 3.6k citations
Yan Sun's Hit Papers
Peers
Comparison fields: 5 of 146
- Acoustics and Ultrasonics 55
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 1.2k
- Cancer Research 458
- Health Informatics 38
Countries citing papers authored by Yan Sun
This map shows the geographic impact of Yan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Sun more than expected).
Fields of papers citing papers by Yan Sun
This network shows the impact of papers produced by Yan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Sun. The network helps show where Yan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Hit paper breakdown → | 2012 | 778 |
| 2 | 2020 | 304 | |
| 3 | 2014 | 154 | |
| 4 | 2007 | 106 | |
| 5 | 2011 | 100 | |
| 6 | 2016 | 88 | |
| 7 | 2009 | 87 | |
| 8 | 2014 | 84 | |
| 9 | 1998 | 83 | |
| 10 | 2015 | 78 | |
| 11 | 2020 | 69 | |
| 12 | 2018 | 69 | |
| 13 | 2011 | 66 | |
| 14 | 2008 | 63 | |
| 15 | 2014 | 61 | |
| 16 | 2013 | 60 | |
| 17 | 2014 | 57 | |
| 18 | 2011 | 47 | |
| 19 | 2012 | 47 | |
| 20 | 2013 | 46 |
About Yan Sun
Yan Sun is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Cancer Research, having authored 132 papers that have together received 3.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (8 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers), Ovarian cancer diagnosis and treatment (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cardiovascular Syncope and Autonomic Disorders (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Acoustics and Ultrasonics (55 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (1.2k citations), Cancer Research (458 citations) and Health Informatics (38 citations). Yan Sun has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Xiangchun Li, Meng Yang, Shuhao Wang, Yahui Jiang, James Chih‐Hsin Yang, Keunchil Park, Mengzhao Wang, Lucio Crinò, Sang-We Kim and Wu‐Chou Su. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Modern Pathology, Frontiers in Pediatrics and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.